These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 9766465)

  • 1. The novel enzymatic 3''-N-acetylation of arbekacin by an aminoglycoside 3-N-acetyltransferase of Streptomyces origin and the resulting activity.
    Hotta K; Sunada A; Ishikawa J; Mizuno S; Ikeda Y; Kondo S
    J Antibiot (Tokyo); 1998 Aug; 51(8):735-42. PubMed ID: 9766465
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enzymatic 2'-N-acetylation of arbekacin and antibiotic activity of its product.
    Hotta K; Zhu CB; Ogata T; Sunada A; Ishikawa J; Mizuno S; Ikeda Y; Kondo S
    J Antibiot (Tokyo); 1996 May; 49(5):458-64. PubMed ID: 8682723
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of aminoglycoside 6'-acetyltransferase in a novel multiple aminoglycoside resistance of an actinomycete strain #8: inactivation of aminoglycosides with 6'-amino group except arbekacin and neomycin.
    Zhu CB; Sunada A; Ishikawa J; Ikeda Y; Kondo S; Hotta K
    J Antibiot (Tokyo); 1999 Oct; 52(10):889-94. PubMed ID: 10604758
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Semisynthetic aminoglycoside antibiotics: Development and enzymatic modifications.
    Kondo S; Hotta K
    J Infect Chemother; 1999 Mar; 5(1):1-9. PubMed ID: 11810483
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel arbekacin- and amikacin-modifying enzyme of methicillin-resistant Staphylococcus aureus.
    Fujimura S; Tokue Y; Takahashi H; Kobayashi T; Gomi K; Abe T; Nukiwa T; Watanabe A
    FEMS Microbiol Lett; 2000 Sep; 190(2):299-303. PubMed ID: 11034295
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Double stage activity in aminoglycoside antibiotics.
    Hotta K; Sunada A; Ikeda Y; Kondo S
    J Antibiot (Tokyo); 2000 Oct; 53(10):1168-74. PubMed ID: 11132963
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Specificity of 4'''-acetylation by an aminoglycoside-modifying enzyme in arbekacin-resistant strains of methicillin-resistant Staphylococcus aureus.
    Fujimura S; Tokue Y; Takahashi H; Nukiwa T; Watanabe A
    Tohoku J Exp Med; 1998 Sep; 186(1):67-70. PubMed ID: 9915109
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A newly recognized acetylated metabolite of arbekacin in arbekacin-resistant strains of methicillin-resistant Staphylococcus aureus.
    Fujimura S; Tokue Y; Takahashi H; Nukiwa T; Hisamichi K; Mikami T; Watanabe A
    J Antimicrob Chemother; 1998 Apr; 41(4):495-7. PubMed ID: 9598784
    [No Abstract]   [Full Text] [Related]  

  • 9. AAC(3)-XI, a new aminoglycoside 3-N-acetyltransferase from Corynebacterium striatum.
    Galimand M; Fishovitz J; Lambert T; Barbe V; Zajicek J; Mobashery S; Courvalin P
    Antimicrob Agents Chemother; 2015 Sep; 59(9):5647-53. PubMed ID: 26149994
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of varying the 4''-position of arbekacin derivatives on antibacterial activity against MRSA and Pseudomonas aeruginosa.
    Hiraiwa Y; Minowa N; Usui T; Akiyama Y; Maebashi K; Ikeda D
    Bioorg Med Chem Lett; 2007 Nov; 17(22):6369-72. PubMed ID: 17889537
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of a novel 6'-N-aminoglycoside acetyltransferase, AAC(6')-Iak, from a multidrug-resistant clinical isolate of Stenotrophomonas maltophilia.
    Tada T; Miyoshi-Akiyama T; Dahal RK; Mishra SK; Shimada K; Ohara H; Kirikae T; Pokhrel BM
    Antimicrob Agents Chemother; 2014 Oct; 58(10):6324-7. PubMed ID: 25092711
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activity of the semi-synthetic kanamycin B derivative, arbekacin against methicillin-resistant Staphylococcus aureus.
    Hamilton-Miller JM; Shah S
    J Antimicrob Chemother; 1995 Jun; 35(6):865-8. PubMed ID: 7559197
    [TBL] [Abstract][Full Text] [Related]  

  • 13. novel 6'-n-aminoglycoside acetyltransferase AAC(6')-Iaj from a clinical isolate of Pseudomonas aeruginosa.
    Tada T; Miyoshi-Akiyama T; Shimada K; Shimojima M; Kirikae T
    Antimicrob Agents Chemother; 2013 Jan; 57(1):96-100. PubMed ID: 23070167
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and antibacterial activity of 5-deoxy-5-episubstituted arbekacin derivatives.
    Hiraiwa Y; Usui T; Akiyama Y; Maebashi K; Minowa N; Ikeda D
    Bioorg Med Chem Lett; 2007 Jul; 17(13):3540-3. PubMed ID: 17502146
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and antibacterial activity of 4″ or 6″-alkanoylamino derivatives of arbekacin.
    Sasaki K; Kobayashi Y; Kurihara T; Yamashita Y; Takahashi Y; Miyake T; Akamatsu Y
    J Antibiot (Tokyo); 2015 Dec; 68(12):741-7. PubMed ID: 25990952
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro and in vivo antimicrobial activity of TS2037, a novel aminoglycoside antibiotic.
    Hirai Y; Maebashi K; Fushimi H; Hiraiwa Y; Murakami S; Usui T; Akiyama Y; Minowa N; Ikeda D
    J Antibiot (Tokyo); 2018 Mar; 71(3):363-371. PubMed ID: 29348522
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Relationship between arbekacin-susceptibility and aminoglycoside-resistant gene of methicillin-resistant Staphylococcus aureus (MRSA)].
    Tabata M; Shimizu M; Araake M; Ogawa H
    Jpn J Antibiot; 2003 Feb; 56(1):36-43. PubMed ID: 12723397
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New 2''-amino derivatives of arbekacin, potent aminoglycoside antibiotics against methicillin-resistant Staphylococcus aureus.
    Kondo S; Shibahara S; Usui T; Kudo T; Tamura A; Gomi S; Ikeda Y; Ikeda D; Takeuchi T
    J Antibiot (Tokyo); 1993 Mar; 46(3):531-4. PubMed ID: 8478274
    [No Abstract]   [Full Text] [Related]  

  • 19. Comparative studies of the bactericidal, morphological and post-antibiotic effects of arbekacin and vancomycin against methicillin-resistant Staphylococcus aureus.
    Watanabe T; Ohashi K; Matsui K; Kubota T
    J Antimicrob Chemother; 1997 Apr; 39(4):471-6. PubMed ID: 9145819
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular mechanism for the enhancement of arbekacin resistance in a methicillin-resistant Staphylococcus aureus.
    Matsuo H; Kobayashi M; Kumagai T; Kuwabara M; Sugiyama M
    FEBS Lett; 2003 Jul; 546(2-3):401-6. PubMed ID: 12832077
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.